🔗 Share this article

Given that the US undertakes historic changes to its vaccine recommendations, a particular individual has surfaced in a surprising turn: Tracy Beth Høeg, a US-based physician and public health researcher who initially gained attention by questioning Covid vaccinations during the global health crisis and has focused upon potential fatalities following COVID-19 vaccination in her brief tenure at the FDA.

Proposed Shifts to Childhood Vaccine Program

Health officials were set to reveal radical changes to the childhood immunization program recently, bringing the US with the Danish immunization schedule, it is understood – a significant shift that would put the US at odds with many the international standard with insufficient data for improved outcomes. The planned update has been pushed back until the next year.

Instead of the director of the vaccine center, Høeg is scheduled to speak at the event. She was just designated temporary leader of the FDA’s CDER, the fifth appointee to head the office this calendar year.

Consolidating Power at the Agency

Høeg's temporary position could signify a tighter collaboration between the drug and biologics centers as Dr. Høeg and Prasad consolidate power at the agency – and it signals a greater focus upon rolling back already-approved vaccines at the FDA.

Dr. Høeg has often pushed for ending specific childhood vaccine recommendations in the US to become more like the Danish model, a nation with nationalized medicine and a population about the population of Wisconsin’s.

So far public appearances, she has kept her attention on immunizations – traditionally the responsibility of Dr. Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – instead of medication approval.

Questions Over Background

Dr. Høeg has no obvious experience in pharmaceutical research, regulation or management, which has been standard for former directors of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a top consultant to the agency head and the vaccine center since earlier this year.

“It seems she lacks to have the requisite experience” for leading the CDER, said a neurologist and psychiatrist. “She has not conducted a scientific study. She lacks experience in managing a large organization. She lacks background in pharmaceutical oversight.”

Past directors of the center would “understand legal statutes and the underlying principles of drug development”, commented Dr. Janet Woodcock. “Objectively, she doesn’t have the sort of resume that former directors who ran CBER have had.”

CDER has an vast workload at the FDA, the former commissioner pointed out.

“Everybody just zeroes in on the novel medication approvals, but the off-patent medication office authorizes a multitude of off-brand pharmaceuticals. There’s a biologic copycat branch, OTC medication office and more, and every single one need to be managed,” Woodcock noted. “The area you overlook, that is the part that I always told people is going to cause problems.”

Furthermore, a substantial management aspect to the position, which oversees over 5,000 staff members. “It’s a massive management job, if you perform it correctly,” the former official concluded.

Agency Reaction and Disputed Policies

In response to concerns about Høeg’s fitness for the role and whether this selection indicates increased cooperation among regulatory chiefs on vaccines, a spokesperson stated that the “concerns are based on flawed presumptions”.

“Her resume is consistent with the responsibilities of her job,” the official explained, noting the period Dr. Høeg spent advising the agency head on “drug safety and approval science, including computational safety modeling and immunization monitoring”.

As the temporary head, Dr. Høeg assumes responsibility for the agency head's controversial fast-track approval initiative, a controversial one-day drug-approval program that reportedly concerned her former heads. “How are these medications being chosen for this expedited pathway? Who is making the choices?” Howard asked. “There’s a lot of secrecy happening at the FDA right now.”

Broadly speaking, he said, “the FDA looks to be trending towards less stringent rules of all drugs, except for vaccines.”

Established Track Record on Immunizations

Concerning vaccines, Dr. Høeg has a more established, if troubling, track record, some experts have noted. She released a research paper using non-validated crowd-sourced reports to estimate the frequency of heart inflammation following Covid vaccination. She counseled the state of Florida surgeon general Joseph Ladapo, who reportedly have modified findings to indicate Covid vaccines are pose a greater threat than they are.

Among her “desired changes” for the incoming administration encompassed changing guidelines for new vaccines and halting “unnecessary” immunizations, she said post-election on a online show. At the agency, Dr. Høeg has allegedly floated the idea of barring young men from receiving Covid vaccinations.

“She is an thorough dogmatist who starts off with her beliefs and works backwards to fit the science in a very misleading, fraudulent way,” Dr. Howard stated.

Consolidating Power and a “Push for Payback”

Dr. Høeg became part of fellow contrarians, {like|